InMode Ltd. (INMD)

Market Cap	1.31B
Revenue (ttm)	394.82M
Net Income (ttm)	181.28M
Shares Out	69.56M
EPS (ttm)	2.25
PE Ratio	8.40
Forward PE	9.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	755,191
Open	19.02
Previous Close	18.97
Day's Range	18.74 - 19.24
52-Week Range	14.87 - 23.46
Beta	2.13
Analysts	Buy
Price Target	22.25 (+17.73%)
Earnings Date	Feb 4, 2025

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedu...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2019
• Employees: 599
• Stock Exchange: NASDAQ
• Ticker Symbol: INMD
• Website: https://www.inmodemd.com

Financial Performance

In 2024, InMode's revenue was $394.82 million, a decrease of -19.76% compared to the previous year's $492.05 million. Earnings were $181.28 million, a decrease of -8.41%.

Analyst Forecast

According to 5 analysts, the average rating for INMD stock is "Buy." The 12-month stock price forecast is $22.25, which is an increase of 17.73% from the latest price.

Price Target

$22.25

(17.73% upside)

Analyst Consensus: Buy